Intravenous iron
Sponsors
Chulalongkorn University, Chiang Mai University, Hospital Universitari de Bellvitge, Leiden University Medical Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions
AnemiaESRD who receiving erythropoietin stimulating agent.
Ret-He, ESRD, functional iron deficiency anemiaGynecologic CancerHemodialysis ComplicationInfective EndocarditisInflammatory Bowel DiseasesIron Deficiency AnemiaIron-deficiency
Phase 1
Phase 2
Phase 3
Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy
CompletedNCT01435200
Start: 2011-06-30End: 2012-11-30Updated: 2017-02-01
Intravenous Versus Oral Iron Therapy in Hemodialysis Patients
NCT04464850
Start: 2020-07-29End: 2022-07-31Target: 124Updated: 2020-08-11
Ret-he level in CKD patients receiving ESA
RecruitingTCTR20220304001
Start: 2022-01-11Target: 140Updated: 2026-03-30
Phase 4
Unknown Phase
.Patient Blood Management Program in Liver Transplantation
NCT05187637
Start: 2022-03-23End: 2023-04-24Target: 66Updated: 2023-03-31
Management of Anemia in Patients with EndocaRditis Infectious Candidates for Cardiac Surgery: the AMERICA Study
Not yet recruitingNCT06583902
Start: 2024-10-31End: 2025-10-30Target: 100Updated: 2024-09-04